Show simple item record

dc.contributor.authorBridgewater, J
dc.contributor.authorPugh, S
dc.contributor.authorWhitehead, A
dc.contributor.authorStanton, L
dc.contributor.authorEminton, Z
dc.contributor.authorMellor, J
dc.contributor.authorAllen, A
dc.contributor.authorFinch-Jones, M
dc.contributor.authorFalk, S
dc.contributor.authorIveson, T
dc.contributor.authorRees, M
dc.contributor.authorValle, Juan W
dc.contributor.authorHornbuckle, J
dc.contributor.authorHickish, T
dc.contributor.authorCunningham, D
dc.contributor.authorMaughan, T
dc.contributor.authorGarden, J
dc.contributor.authorGriffiths, G
dc.contributor.authorPrimrose, J
dc.date.accessioned2017-11-23T21:29:01Z
dc.date.available2017-11-23T21:29:01Z
dc.date.issued2017-09
dc.identifier.citation483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial. 2017, 28(suppl_5): Ann Oncolen
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.doi10.1093/annonc/mdx393.010
dc.identifier.urihttp://hdl.handle.net/10541/620695
dc.language.isoenen
dc.relation.urlhttp://academic.oup.com/annonc/article/doi/10.1093/annonc/mdx393.010/4109782/483PDPerioperative-chemotherapy-with-or-withouten
dc.rightsArchived with thanks to Annals of Oncologyen
dc.title483PD Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): mature analysis of overall survival (OS) in the New EPOC randomised controlled trial.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentOncology, UCL Cancer Institute/Paul O’Gorman Building, Londonen
dc.identifier.journalAnnals of Oncologyen


This item appears in the following Collection(s)

Show simple item record